The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Valeria Santini

University of Florence

AOU Careggi

Firenze

Italy. Electronic address:

[email]@unifi.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • University of Florence, AOU Careggi, Firenze, Italy. Electronic address:. 2012
  • Functional Unit of Haematology, AOU Careggi, University of Florence, Firenze, Italy. 2001 - 2010
  • UF Ematologia, Azienda Ospedaliero-Universitaria (AOU) Careggi, Università degli Studi di Firenze, Florence, Italy. 2009
  • Dept. of Hematology, Policlinico di Careggi, viale Morgagni 85, 50134 Florence, Italy. 1999 - 2002

References

  1. Treatment of low-risk myelodysplastic syndrome: hematopoietic growth factors erythropoietins and thrombopoietins. Santini, V. Semin. Hematol. (2012) [Pubmed]
  2. Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines. Santini, V., Alessandrino, P.E., Angelucci, E., Barosi, G., Billio, A., Di Maio, M., Finelli, C., Locatelli, F., Marchetti, M., Morra, E., Musto, P., Visani, G., Tura, S. Leuk. Res. (2010) [Pubmed]
  3. Azacitidine: activity and efficacy as an epigenetic treatment of myelodysplastic syndromes. Santini, V. Expert. Rev. Hematol (2009) [Pubmed]
  4. Azacitidine in lower-risk myelodysplastic syndromes. Santini, V. Leuk. Res. (2009) [Pubmed]
  5. Treatment options in myelodysplastic syndromes: a new frontier. Santini, V., Gozzini, A., Bosi, A. J. Chemother (2008) [Pubmed]
  6. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application. Santini, V., Gozzini, A., Ferrari, G. Curr. Drug Metab. (2007) [Pubmed]
  7. The carboxy-terminal region of the granulocyte colony-stimulating factor receptor transduces a phagocytic signal. Santini, V., Scappini, B., Indik, Z.K., Gozzini, A., Ferrini, P.R., Schreiber, A.D. Blood (2003) [Pubmed]
  8. Lyn kinase is activated following thrombopoietin stimulation of the megakaryocytic cell line B1647. Santini, V., Scappini, B., Grossi, A., Gozzini, A., Bonsi, L., Pagliai, G., Rossi Ferrini, P., Bagnara, G.P. Haematologica (2002) [Pubmed]
  9. Amifostine: chemotherapeutic and radiotherapeutic protective effects. Santini, V. Expert. Opin. Pharmacother (2001) [Pubmed]
  10. Searching for the magic bullet against cancer: the butyrate saga. Santini, V., Gozzini, A., Scappini, B., Grossi, A., Rossi Ferrini, P. Leuk. Lymphoma (2001) [Pubmed]
  11. Maturation and apoptosis of primary human acute myeloblastic leukemia cells are determined by TNF-alpha exclusively through CD120A stimulation. Santini, V., Gozzini, A., Scappini, B., Rossi Ferrini, P. Haematologica (1999) [Pubmed]
  12. Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells. Santini, V., Gozzini, A., Scappini, B., Caporale, R., Zoccolante, A., Rigacci, L., Gelardi, E., Grossi, A., Alterini, R., Ferrini, P.R. Haematologica (1999) [Pubmed]
  13. The potential of amifostine: from cytoprotectant to therapeutic agent. Santini, V., Giles, F.J. Haematologica (1999) [Pubmed]
 
WikiGenes - Universities